期刊文献+

LEEP刀联合保妇康栓治疗高危型HPV感染CIN的临床观察 被引量:25

Efficacy of LEEP knife combined with Baofukang suppository in the treatment of CIN and high risk- HPV infection
下载PDF
导出
摘要 目的:探讨高危型HPV感染CIN患者的治疗方法,为高危型HPV感染CIN患者的早期治疗寻求新途径。方法:对2006年3月至2010年6月在我院诊断的高危型HPV感染的CIN患者140例进行随机分组后治疗,分为LEEP联合保妇康栓组、LEEP组,治疗后随访2年,复查监测指标,观察每组的治疗效果。结果:LEEP组治疗后6个月、12个月、18个月及2 4个月的高危型HPV清除率分别为80.0%、82.9%、84.3%、92.9%,LEEP联合保妇康栓组的分别为82.9%、94.3%、95.7%、98.6%,2组相比有显著性差异。治疗后2年的宫颈活检结果显示LEEP联合保妇康栓组的CIN率低于LEEP组。结论:LEEP联合保妇康栓治疗可提高高危型HPV感染CIN患者的HPV清除率,降低CIN复发率,优于其他单一治疗方法。 Objective:To investigate the clinical efficacy of LFLEP combined with Baofukang suppository, in the treatment of cervical intraepithelial neoplasia(CIN) patients with high risk human papillomavirus(hr- HPV) infec- tion. Methods:From 2006 March to 2010 June,140 women diagnosed as CIN combined with hr - HPV infection were randomly divided into 2 groups:LEEP + Baofukang suppository group(n=70) and LEEP group (n=70). To observe the monitoring indicators and curative effect in two years after treatment. Results: LEEP group, hr - HPV clearance rates were 80% ,82.9% ,84.3%, 92.9% after treatment for 6 months, 12 months, 18 months and 24 months; in LEEP combined with Baofukang suppository group were 82.9% ,94.3% ,95.7% ,98.6%. The results showed the in- cidence of CIN in LEEP combined with Baofukang suppository, groups were lower than the LEEP group. Conclusion: LEEP combined with Baofukang suppository in the treatment of CIN and hr - HPV infection can improve the HPV re- moval rate and reduce the recurrence rate of CIN,which is better than LEEP group.
机构地区 西安凤城医院
出处 《现代肿瘤医学》 CAS 2014年第3期628-630,共3页 Journal of Modern Oncology
基金 西安市未央区科技局(编号:200916)
关键词 高危型HPV感染 宫颈上皮内瘤变 LEEP联合保妇康栓治疗 high - risk HPV infection CIN LEEP combined with Baofukang suppository
  • 相关文献

参考文献8

二级参考文献56

  • 1沈铿.宫颈上皮内瘤变治疗方法的选择[J].中华医学杂志,2006,86(5):291-294. 被引量:91
  • 2舒青青,王飞雪,陆晓青,龚庆玲.阴道镜图像对宫颈上皮内瘤样变的诊断价值[J].中国妇幼保健,2006,21(24):3465-3466. 被引量:16
  • 3钱德英.重视宫颈癌前病变筛查的质量管理控制[J].中国实用妇科与产科杂志,2007,23(7):497-498. 被引量:102
  • 4Sarian LO, Derchain SF, Andrade LA, et al. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol, 2004,94 : 181-186.
  • 5Numnum TM, Kirby To, Leath CA 3rd, et al. A prospective evaluation of "see and treat" in women with HSIL . Pap smear results : is this an appropriate strategy? J Low Genit Tract Dis, 2005,9:2-6.
  • 6Livasy CA, Maygarden SJ, Rajaratnam CT, et al. Predictors of recurrent dysplasia after a cervical loop electrocautery excision procedure for CIN-3: a study of margin, endocervical gland, and quadrant involvement . Mod Pathol, 1999,12 : 233-238.
  • 7Reich O, Pickel H, Lahousen M, et al. Cervical intraepithelial neoplasia Ⅲ: long-term outcome after cold-knife conization with clear margins. Obstet Gynecol, 2001,97:428-430.
  • 8Kang SB, Roh JW, Kim JW, et al. A comparison of the therapeutic efficacies of large loop excision of transformation zone and hysterectomy for the treatment of cervical intraepithelial neoplasia Ⅲ.Int J Gynecol Cancer, 2001,11:387-391.
  • 9Corona Gutierrez CM, Tinoco A, Navarro T, et al. Therapeutic vaccination with MVAE2 can eliminate precancerous lesions associated with infection by oncogenic human papillomavims. Human Gene Ther, 2004, 15:421-431.
  • 10Yamaguchi S, Tsuda H, Takemori M, et al. Photodynamic therapy for cervical intraepithelial neoplasia. Ontology, 2005,69 : 110-116.

共引文献246

同被引文献199

引证文献25

二级引证文献185

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部